Scientifically reduce the use of antibiotics with high drug resistance rates to ensure the health of patients and effectively reduce medical insurance costs

The implementation plan of the 2020 inpatient prepayment system (IPPS) announced by the Centers for Medical Insurance and Public Medicaid Services (CMS) in the United States

1.

The U.

Due to the cancellation of the "significant clinical advantage" requirement in the United States, new antibiotics that have been certified by QIDP can enter the United States NTAP.

The latest American concept is to subvert the original wrong concept: first use new antibiotics symptomatically and rationally to reduce the resistance of drug-resistant bacteria, which means that new and better antibiotics should be used as early as possible to treat bacterial infections, especially anti-resistant.

Recently, based on the actual development of clinical drug-resistant bacteria in modern times, the United States has overturned the traditional misconceptions and proposed to give priority to the use of new antibiotics to effectively reduce the production of drug-resistant bacteria.

For example: if penicillin is used, it has no effect after reaching 9.

Anti-infective drugs are rich in varieties and types, with a market size of more than 200 billion yuan, and systemic antibacterial drugs account for more than 80% of the entire systemic anti-infective drugs in the hospital market

Both cefoperazone and sulbactam and piperacillin and tazobactam are produced or marketed by US-funded enterprises

Both cefoperazone and sulbactam and piperacillin and tazobactam are produced or marketed by US-funded enterprises

But it is worth noting that the unilateral cefoperazone has been delisted in the United States

Have such old antibiotics been restricted in China's strict antibiotic management? Not really

For various complicated reasons, the enthusiasm of domestic pharmaceutical companies for the research and development of new antibiotics is rapidly declining

The United States has already taken action to reduce its dependence on China in the production of APIs

Antibiotic resistance is a scientific issue.
The treatment of drug-resistant infections is quickly becoming the norm.
The emergence of multi-drug-resistant bacteria in large numbers is a serious threat to human health
.
At the G20 Hangzhou Summit, the Chinese government promised to give priority and preferential support to China’s own companies to develop new anti-drug resistant antibiotics
.
According to the implementation of the IPPS new antibiotic use plan in the United States in 2020, the United States encourages clinicians to use new antibiotics for symptomatic treatment first, so that treatment can be performed within the effective time window, which can more effectively protect lives, shorten treatment time, save treatment costs, and effectively prevent drug resistance The production of bacteria
.
Antibiotic resistance is a scientific issue.
The treatment of drug-resistant infections is quickly becoming the norm.
The emergence of multi-drug-resistant bacteria in large numbers is a serious threat to human health
.
At the G20 Hangzhou Summit, the Chinese government promised to give priority and preferential support to China’s own companies to develop new anti-drug resistant antibiotics
.
According to the implementation of the IPPS new antibiotic use plan in the United States in 2020, the United States encourages clinicians to use new antibiotics for symptomatic treatment first, so that treatment can be performed within the effective time window, which can more effectively protect lives, shorten treatment time, save treatment costs, and effectively prevent drug resistance The production of bacteria
.

my country must strictly restrict antibiotics that have a resistance rate of more than 40% or 50%, such as cefoperazone sodium and sulbactam sodium, piperacillin tazobactam, piperacillin sodium, amoxicillin sodium, cefoperazone sodium, ceftriaxone sodium , Cefotaxime sodium and other antibiotics that are already very resistant.
.
.

China must strictly limit antibiotics that have a resistance rate of more than 40% or 50%, such as cefoperazone sodium and sulbactam sodium, piperacillin tazobactam, piperacillin sodium, amoxicillin sodium, cefoperazone sodium, ceftriaxone sodium , Cefotaxime sodium, etc.
, which are already very resistant to antibiotics.
.
.
China must strictly limit antibiotics that have a resistance rate of more than 40% or 50%, such as cefoperazone sodium and sulbactam sodium, piperacillin, tazobactam, Piperacillin sodium, amoxicillin sodium, cefoperazone sodium, ceftriaxone sodium, cefotaxime sodium, etc.
already have very high resistance antibiotics.
.
.
China must strictly limit antibiotics that have a resistance rate of more than 40% or 50% , Such as Cefoperazone Sodium and Sulbactam Sodium, Piperacillin Tazobactam, Piperacillin Sodium, Amoxicillin Sodium, Cefoperazone Sodium, Ceftriaxone Sodium, Cefotaxime Sodium, etc.
There are already very resistant antibiotics.
.
.

Any drug that has been used for a long time or in a large amount will develop drug resistance and or tolerance to varying degrees.
Therefore, humans need to continuously develop new drugs, especially for antibiotics that have been used in large quantities for a long time.
It’s scientific common sense not to use one or two antibiotics for a long period of time.
️Call on the National Health Commission, Guangdong Provincial Health Commission, Beijing Health Commission, etc.
as well as medical experts and scholars to effectively limit the abuse of cefoperazone sodium and sulbactam sodium for injection and piperacillintazol for injection in accordance with medical science Batan, by periodically adjusting the medication and reducing the use or frequency of these two drugs to reduce drug resistance
.
We must not forget our original intention and the conscience of scientists! ! It is necessary to use new drugs from Chinese companies as much as possible, work together to effectively reduce the resistance of antibiotics, serve the health of the Chinese people, and effectively prevent the national public health infection and epidemic risk
.

 

Any drug that has been used for a long time or in a large amount will develop drug resistance and or tolerance to varying degrees.
Therefore, humans need to continuously develop new drugs, especially for antibiotics that have been used in large quantities for a long time.
It’s scientific common sense not to use one or two antibiotics for a long period of time.
️Call on the National Health Commission, Guangdong Provincial Health Commission, Beijing Health Commission, etc.
as well as medical experts and scholars to effectively limit the abuse of cefoperazone sodium and sulbactam sodium for injection and piperacillintazol for injection in accordance with medical science Batan, by periodically adjusting the medication and reducing the use or frequency of these two drugs to reduce drug resistance
.
We must not forget our original intention and the conscience of scientists! ! It is necessary to use new drugs from Chinese companies as much as possible, work together to effectively reduce the resistance of antibiotics, serve the health of the Chinese people, and effectively prevent the national public health infection and epidemic risk
.
Any drug that has been used for a long time or in a large amount will develop drug resistance and or tolerance to varying degrees.
Therefore, humans need to continuously develop new drugs, especially for antibiotics that have been used in large quantities for a long time.
It’s scientific common sense.
️Call on the National Health Commission, Guangdong Provincial Health Commission, Beijing Health Commission, etc.
as well as medical experts and scholars to effectively limit the abuse of cefoperazone sodium and sulbactam sodium for injection and piperacillintazol for injection in accordance with medical science Batan, by periodically adjusting the medication and reducing the use or frequency of these two drugs to reduce drug resistance
.
We must not forget our original intention and the conscience of scientists! ! It is necessary to use new drugs from Chinese companies as much as possible, work together to effectively reduce the resistance of antibiotics, serve the health of the Chinese people, and effectively prevent the national public health infection and epidemic risk
.

Small pills with great energy, quick-acting heart-relief pills to save the heart at critical moments